BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 971 filers reported holding BAXTER INTL INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $202,000 | -18.2% | 3,743 | -2.6% | 0.02% | -13.6% |
Q2 2022 | $247,000 | -20.3% | 3,843 | -3.8% | 0.02% | -4.3% |
Q1 2022 | $310,000 | -11.2% | 3,996 | -1.6% | 0.02% | -4.2% |
Q4 2021 | $349,000 | +6.1% | 4,061 | -0.5% | 0.02% | 0.0% |
Q3 2021 | $329,000 | -3.2% | 4,083 | -3.2% | 0.02% | -4.0% |
Q2 2021 | $340,000 | -4.5% | 4,218 | 0.0% | 0.02% | -7.4% |
Q1 2021 | $356,000 | -4.3% | 4,218 | -8.8% | 0.03% | -10.0% |
Q4 2020 | $372,000 | -0.3% | 4,625 | 0.0% | 0.03% | -3.2% |
Q3 2020 | $373,000 | -25.1% | 4,625 | -20.1% | 0.03% | -24.4% |
Q2 2020 | $498,000 | +10.2% | 5,787 | +4.0% | 0.04% | +5.1% |
Q1 2020 | $452,000 | -11.9% | 5,565 | -9.4% | 0.04% | -15.2% |
Q4 2019 | $513,000 | -17.1% | 6,142 | -13.2% | 0.05% | -24.6% |
Q3 2019 | $619,000 | -9.0% | 7,072 | -14.7% | 0.06% | -7.6% |
Q2 2019 | $680,000 | -1.6% | 8,294 | -2.3% | 0.07% | -1.5% |
Q1 2019 | $691,000 | +28.0% | 8,491 | +3.5% | 0.07% | +11.7% |
Q4 2018 | $540,000 | -13.6% | 8,203 | +1.1% | 0.06% | -3.2% |
Q3 2018 | $625,000 | +27.8% | 8,114 | +22.7% | 0.06% | +40.9% |
Q2 2018 | $489,000 | +13.7% | 6,614 | 0.0% | 0.04% | +12.8% |
Q1 2018 | $430,000 | -2.3% | 6,614 | -2.8% | 0.04% | -11.4% |
Q4 2017 | $440,000 | -2.2% | 6,807 | -5.0% | 0.04% | -6.4% |
Q3 2017 | $450,000 | +24.7% | 7,168 | +20.2% | 0.05% | +17.5% |
Q2 2017 | $361,000 | +9.1% | 5,962 | -6.5% | 0.04% | +8.1% |
Q1 2017 | $331,000 | +8.5% | 6,375 | -7.4% | 0.04% | +8.8% |
Q4 2016 | $305,000 | -9.8% | 6,887 | -2.9% | 0.03% | -8.1% |
Q3 2016 | $338,000 | +3.4% | 7,093 | -1.7% | 0.04% | +2.8% |
Q2 2016 | $327,000 | -3.3% | 7,217 | -12.3% | 0.04% | -5.3% |
Q1 2016 | $338,000 | – | 8,228 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |